1.0Zhejiang Hengkang Pharmaceuticalhttps://en.hengkangpharm.cnHengkangPharmhttps://en.hengkangpharm.cn/index.php/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="XFdkGwsk4K"><a href="https://en.hengkangpharm.cn/index.php/apis/mesalazine_mesalamine/">Mesalazine/Mesalamine API</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://en.hengkangpharm.cn/index.php/apis/mesalazine_mesalamine/embed/#?secret=XFdkGwsk4K" width="600" height="338" title="“Mesalazine/Mesalamine API” — Zhejiang Hengkang Pharmaceutical" data-secret="XFdkGwsk4K" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://en.hengkangpharm.cn/wp-includes/js/wp-embed.min.js </script> Mesalamine (USAN), also known as 5-aminosalicylic acid (5-ASA), is primarily indicated to treat inflammatory bowel disease and is effective in inducing or maintaining remission in mild-to-moderate cases of ulcerative colitis. Topical mesalamine stands as the first-line treatment for this condition. Clinicians may use 5-ASA off-label in Crohn disease following surgical resection of the affected bowel. Although patients with ulcerative colitis typically receive 5-ASA prescriptions from their managing gastroenterologist or primary care clinician, a surgeon may become involved in off-label uses. This activity provides healthcare professionals with a comprehensive understanding of mesalamine, covering FDA-approved indications, mechanisms of action, administration strategies, contraindications, and adverse effects profile. This activity also highlights the crucial role of the interprofessional healthcare team in effectively treating patients with ulcerative colitis, inflammatory bowel disease, and related conditions by enhancing their understanding of mesalamine's indications. Oral mesalazine (also known as mesalamine) is a 5-aminosalicylic acid compound used in the treatment of mild to moderate ulcerative colitis, with high rates of efficacy in induction and maintenance of remission. The therapeutic effect of mesalazine occurs topically at the site of diseased colonic mucosa. A myriad of oral mesalazine preparations have been formulated with various drug delivery methods to minimize systemic absorption and maximise drug availability at the inflamed colonic epithelium. It remains unclear whether different oral mesalazine formulations are bioequivalent. This review aims to evaluate the differences between mesalazine formulations based on the currently available literature and explore factors which may influence the selection of one agent above another.https://en.hengkangpharm.cn/wp-content/uploads/2024/01/蓝色绿色分子banner1-2.png1175200